Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...
Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
More than 20 COVID vaccines are in use globally, each one based on the ancestral coronavirus SARS-CoV-2 that surfaced in Wuhan, China, over two years ago. Among them, mRNA vaccines are believed to ...
Pfizer started its 25,000-person phase 3 trial Sept. 14 to test the efficacy of a flu vaccine candidate that uses the same mRNA technology as its COVID-19 vaccine. In mid-June, Moderna began enrolling ...
Moderna has filed a lawsuit against Pfizer and its German partner BioNTech for allegedly copying their COVID-19 vaccine. On Friday, Moderna issued a news release accusing Pfizer of infringing several ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects ...
The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback